Clinical Trials Browser

Recruiting × OTHER × Adenocarcinoma of Lung × Clear all

NCT06843629 2026-05-28

Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

GastrointestinalGynecologicThoracic

Adenocarcinoma of Lung, Ovarian Neoplasms, Pancreatic Neoplasms

NCT05191485 2026-04-30

Shared Decision Making in Patients With Lung Cancer

Adenocarcinoma of Lung

NCT05528458 2026-04-28

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma of Lung

NCT04937283 2026-04-13

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Phase NA Recruiting

Adenocarcinoma of Lung

NCT06181812 2026-04-08

Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Adenocarcinoma of Lung

NCT06495125 2026-04-06

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT07481786 2026-04-06

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Phase 3 Recruiting

Adenocarcinoma of Lung, Brain Neoplasms

NCT05665504 2026-04-01

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Adenocarcinoma of Lung

NCT07479095 2026-03-20

KETO-FDG Lung

Phase NA Recruiting

Adenocarcinoma of Lung

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Phase 1 Recruiting

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT07012759 2026-03-05

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Adenocarcinoma of Lung, Lung Neoplasms, Pleural Effusion

NCT07219251 2026-03-03

EVLC

Phase NA Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT07423169 2026-02-20

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

Phase NA Recruiting

Adenocarcinoma of Lung

NCT03199651 2026-02-19

BLCIO

Phase NA Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT07235280 2026-02-19

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Phase EARLY_PHASE1 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT04339218 2026-01-30

CRYOMUNE

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT05558904 2025-11-10

An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Phase 1/2 Recruiting

Adenocarcinoma of Lung

NCT07116057 2025-10-10

MOv19-BBz CAR T Cells in FRa+ Cancers

Phase 1 Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07161713 2025-09-23

RESET

Phase NA Recruiting

GastrointestinalThoracic

Adenocarcinoma of Lung, Colonic Neoplasms, Disease, Lung Neoplasms

NCT04105270 2025-09-11

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms

NCT05517811 2025-01-28

TEG

GastrointestinalThoracic

Adenocarcinoma of Lung, Biliary Tract Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06745830 2024-12-20

Lymph Node Pathologic Grading Strategy

Adenocarcinoma of Lung

NCT05925764 2024-10-21

WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma

Adenocarcinoma of Lung

NCT06634966 2024-10-10

Segmentectomy for Solid-dominant Lung Cancer

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT05830812 2024-09-19

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

Adenocarcinoma of Lung

NCT06528847 2024-07-31

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT06441357 2024-06-04

Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter

Adenocarcinoma of Lung

NCT05717803 2024-06-03

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT05266846 2024-05-30

BEYOND

Phase 2 Recruiting

Adenocarcinoma of Lung

NCT06255197 2024-02-16

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

60,000 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT06031181 2023-12-13

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

Phase 3 Recruiting

Adenocarcinoma of Lung

NCT05550961 2023-10-23

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Phase NA Recruiting

Adenocarcinoma of Lung

NCT06031246 2023-09-11

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Phase 3 Recruiting

Adenocarcinoma of Lung, Lymphatic Metastasis

NCT05838053 2023-07-27

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Adenocarcinoma of Lung

NCT05733000 2023-03-10

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Phase 2 Recruiting

GastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05537922 2023-01-06

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT05503667 2022-08-17

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma of Lung

NCT03351842 2017-12-19

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Phase 2 Recruiting

Adenocarcinoma of Lung, Neoplasms by Histologic Type